Affiliation: Hospital Vall d'Hebron
- Emotional state of patients with relapsing-remitting MS treated with interferon beta-1bC Borras
Unit of Clinical Neuroimmunology, Hospital Vall d Hebron, Barcelona, Spain
Neurology 52:1636-9. 1999..Depression has been cited as a possible side effect of interferon beta-1b (IFNbeta-1b) therapy in patients with MS. This association remains unproven because of a lack of longitudinal studies...
- A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosisX Montalban
Unitat de Neuroimmunologia Clinica, Multiple Sclerosis Centre of Catalonia CEM Cat, Barcelona, Spain
Mult Scler 15:1195-205. 2009..Positive effects of interferon beta on secondary clinical and magnetic resonance imaging outcomes were observed, but a beneficial effect on Expanded Disability Status Scale progression was not demonstrated...
- Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMSM Tintore
Unit of Clinical Neuroimmunology Department of Neurology, Vall d Hebron University Hospitals, Barcelona, Spain
Mult Scler 7:359-63. 2001..To evaluate and compare the capacity of oligoclonal bands (OB) and three sets of MR imaging criteria to predict the conversion of clinically isolated syndromes (CIS) to clinically definite multiple sclerosis (CDMS)...